KBC Group’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,056
| Closed | -$40K | – | 1863 |
|
|
2024
Q3 | $40K | Buy |
1,056
+519
| +97% | +$21.3K | ﹤0.01% | 1785 |
|
|
2024
Q2 | $24K | Hold |
537
| – | – | ﹤0.01% | 1836 |
|
|
2024
Q1 | $26K | Hold |
537
| – | – | ﹤0.01% | 1800 |
|
|
2023
Q4 | $29K | Hold |
537
| – | – | ﹤0.01% | 1817 |
|
|
2023
Q3 | $31K | Sell |
537
-297
| -36% | -$18.6K | ﹤0.01% | 1772 |
|
|
2023
Q2 | $53K | Hold |
834
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q1 | $52K | Hold |
834
| – | – | ﹤0.01% | 1380 |
|
|
2022
Q4 | $44K | Hold |
834
| – | – | ﹤0.01% | 1424 |
|
|
2022
Q3 | $47K | Sell |
834
-338
| -29% | -$22.3K | ﹤0.01% | 1411 |
|
|
2022
Q2 | $85K | Sell |
1,172
-2,511
| -68% | -$187K | ﹤0.01% | 1286 |
|
|
2022
Q1 | $293K | Hold |
3,683
| – | – | ﹤0.01% | 950 |
|
|
2021
Q4 | $373K | Hold |
3,683
| – | – | ﹤0.01% | 937 |
|
|
2021
Q3 | $340K | Sell |
3,683
-3,683
| -50% | -$354K | ﹤0.01% | 965 |
|
|
2021
Q2 | $754K | Hold |
7,366
| – | – | ﹤0.01% | 972 |
|
|
2021
Q1 | $718K | Hold |
7,366
| – | – | ﹤0.01% | 950 |
|
|
2020
Q4 | $3.12M | Hold |
7,366
| – | – | ﹤0.01% | 949 |
|
|
2020
Q3 | $542K | Buy |
+7,366
| New | +$591K | ﹤0.01% | 922 |
|
|
2020
Q1 | – | Sell |
-3,974
| Closed | -$312K | – | 1446 |
|
|
2019
Q4 | $312K | Buy |
+3,974
| New | +$293K | ﹤0.01% | 1221 |
|
|
2019
Q3 | – | Sell |
-1,087
| Closed | -$86K | – | 1503 |
|
|
2019
Q2 | $86K | Sell |
1,087
-3,645
| -77% | -$289K | ﹤0.01% | 1317 |
|
|
2019
Q1 | $397K | Hold |
4,732
| – | – | ﹤0.01% | 1131 |
|
|
2018
Q4 | $557K | Sell |
4,732
-11,722
| -71% | -$1.36M | 0.01% | 908 |
|
|
2018
Q3 | $1.98M | Buy |
+16,454
| New | +$2.04M | 0.02% | 684 |
|
|
2017
Q1 | – | Sell |
-2,100
| Closed | -$129K | – | 1332 |
|
|
2016
Q4 | $129K | Buy |
+2,100
| New | +$137K | ﹤0.01% | 1241 |
|
|
2016
Q1 | – | Sell |
-2,800
| Closed | -$179K | – | 1303 |
|
|
2015
Q4 | $179K | Sell |
2,800
-1,396
| -33% | -$90.5K | ﹤0.01% | 1006 |
|
|
2015
Q3 | $281K | Sell |
4,196
-1,760
| -30% | -$124K | 0.01% | 924 |
|
|
2015
Q2 | $407K | Sell |
5,956
-1,702
| -22% | -$108K | 0.01% | 953 |
|
|
2015
Q1 | $425K | Buy |
+7,658
| New | +$393K | 0.01% | 944 |
|
|
2014
Q3 | – | Sell |
-2,698
| Closed | -$105K | – | 1338 |
|
|
2014
Q2 | $105K | Hold |
2,698
| – | – | ﹤0.01% | 1199 |
|
|
2014
Q1 | $102K | Hold |
2,698
| – | – | ﹤0.01% | 1128 |
|
|
2013
Q4 | $102K | Sell |
2,698
-686
| -20% | -$26.3K | ﹤0.01% | 1136 |
|
|
2013
Q3 | $147K | Buy |
+3,384
| New | +$136K | ﹤0.01% | 1035 |
|
Other funds holding USNA
KBC Group's USNA Position: Q4 2024 in Review
KBC Group sold out of Usana Health Sciences (USNA) in Q4 2024, closing a stake of 1,056 shares — an estimated $40K sold.
KBC Group first reported a position in USNA in Q3 2013 and held it in 31 quarters. The position peaked at $3.12M in Q4 2020. 152 funds tracked by Wall St. Rank hold USNA as of Q4 2024.
- KBC Group reported no remaining Usana Health Sciences position as of Q4 2024 after selling out during the quarter.
- KBC Group sold 1,056 Usana Health Sciences shares in Q4 2024, an estimated $40K.
- KBC Group first reported a position in Usana Health Sciences in Q3 2013 and held it in 31 quarters.
- KBC Group's Usana Health Sciences position peaked at $3.12M in Q4 2020.
- 152 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2024.
Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.